Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-γ

Journal of Infectious Diseases

Volumn 173, Issue 1, 1996, Pages 7-17

  Mikloska, Zorka ^a   Kesson, Alison M ^a,d   Penfold, Mark E T ^a,c   Cunningham, Anthony L ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; IMMEDIATE EARLY PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHONOACETIC ACID; VIRUS GLYCOPROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; KERATINOCYTE; LYMPHOCYTOTOXICITY; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION;

EID: 0030063162     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.1.7     Document Type: Article

References (14)

1. Schmid DS, Rouse BT. The role of T-cell immunity in control of herpes simplex virus. Curr Top Microbiol Immunol 1992;179:57-75.
2. Rand KH, Rasmussen LE, Pollard RB, Arvin A, Merigan TC. Cellular immunity and herpesvirus infections in cardiac-transplant patients. N Engl J Med 1977;296:1372-7.
3. Siegal FP, Lopez C, Hammer OS, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981;305:1439-44.
4. Corey L, Reeves WC, Holmes KK. Cellular immune response in genital herpes simplex virus infection. N Engl J Med 1978;299:986-91.
5. Cunningham AL, Merigan TC. Gamma interferon production appears to predict time of recurrence of herpes labialis. J Immunol 1983;130:2397-400.
6. Torseth JW, Merigan TC. Significance of local γ-interferon in recurrent herpes simplex infection. J Infect Dis 1986;153:979-84.
7. O'Reilly RJ, Chibarro A, Anger E, Lopez C. Cell mediated immune responses in patients with recurrent herpes simplex infections. II. Infection associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis. J Immunol 1977;118:1095-102.
8. Sheridan JF, Donnenberg AD, Aurelian L, Elpern DJ. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an influence in T-lymphocyte subsets. J Immunol 1982;129:326-31.
9. Cunningham AL, Turner RR, Miller AC, Para MF, Merigan TC. Evolution of recurrent herpes simplex lesions: an immunohistologic study. J Clin Invest 1985;75:226-33.
10. Cunningham AL, Merigan TC. Leu-3 T-cells produce γ-interferon in patients with recurrent herpes labialis. J Immunol 1984;132:197-202.
11. Cunningham AL, Noble JR. Role of keratinocytes in human recurrent herpetic lesions. J Clin Invest 1989;83:490-6.
12. - T-cells and is restricted to the DR region of the MHC complex. J Immunol 1988;140:3610-6.
13. Yasukawa M, Inatsuki A, Horiuchi T, Kobayashi Y. Functional heterogeneity among herpes simplex virus specific human CD4 T-cells. J Immunol 1991;146:1341-7.
14. Zarling JM, Moran PA, Burke RL, Pachl C, Berman PW, Lasky LA. Human cytotoxic T-cells directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. J Immunol 1986;136:4669-73.